|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 40559 |
FusionGeneSummary for UBLCP1_INS-IGF2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: UBLCP1_INS-IGF2 | Fusion gene ID: 40559 | Hgene | Tgene | Gene symbol | UBLCP1 | INS-IGF2 | Gene ID | 134510 | 723961 |
| Gene name | ubiquitin like domain containing CTD phosphatase 1 | INS-IGF2 readthrough | |
| Synonyms | CPUB1 | INSIGF | |
| Cytomap | 5q33.3 | 11p15.5 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ubiquitin-like domain-containing CTD phosphatase 1CTD phosphatase-like with ubiquitin domain 1CTD-like phosphatase domain-containing proteinnuclear proteasome inhibitor UBLCP1 | insulin, isoform 2INS-IGF2 readthrough transcript proteininsulin- insulin-like growth factor 2 read-through product | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q8WVY7 | F8WCM5 | |
| Ensembl transtripts involved in fusion gene | ENST00000296786, | ENST00000481781, ENST00000397270, | |
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 14 X 23 X 1=322 |
| # samples | 2 | 24 | |
| ** MAII score | log2(2/8*10)=1.32192809488736 | log2(24/322*10)=-0.424026282506098 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: UBLCP1 [Title/Abstract] AND INS-IGF2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | UBLCP1 | GO:0006470 | protein dephosphorylation | 21949367 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | N58118 | UBLCP1 | chr5 | 158712193 | - | INS-IGF2 | chr11 | 2153350 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-intron | ENST00000296786 | ENST00000481781 | UBLCP1 | chr5 | 158712193 | - | INS-IGF2 | chr11 | 2153350 | + |
| 3UTR-intron | ENST00000296786 | ENST00000397270 | UBLCP1 | chr5 | 158712193 | - | INS-IGF2 | chr11 | 2153350 | + |
Top |
FusionProtFeatures for UBLCP1_INS-IGF2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| UBLCP1 | INS-IGF2 |
| Dephosphorylates 26S nuclear proteasomes, therebydecreasing their proteolytic activity. The dephosphorylation mayprevent assembly of the core and regulatory particles (CP and RP)into mature 26S proteasome. {ECO:0000269|PubMed:21949367}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for UBLCP1_INS-IGF2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for UBLCP1_INS-IGF2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for UBLCP1_INS-IGF2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for UBLCP1_INS-IGF2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|